666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study

BACKGROUND: Cefiderocol, a novel siderophore cephalosporin with broad activity against Gram-negative bacteria, requires dose adjustment in patients with renal impairment or augmented renal clearance, similarly to other β-lactams. The efficacy and safety of cefiderocol were assessed according to degr...

Descripción completa

Detalles Bibliográficos
Autores principales: Portsmouth, Simon, Echols, Roger, Machida, Mitsuaki, Camilo Arjona Ferreira, Juan, Ariyasu, Mari, Den Nagata, Tsutae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810948/
http://dx.doi.org/10.1093/ofid/ofz360.734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810948/
http://dx.doi.org/10.1093/ofid/ofz360.734

Ejemplares similares